[go: up one dir, main page]

Shore-Lesserson, 2005 - Google Patents

Evidence based coagulation monitors: heparin monitoring, thromboelastography, and platelet function

Shore-Lesserson, 2005

Document ID
18209957765907322161
Author
Shore-Lesserson L
Publication year
Publication venue
Seminars in cardiothoracic and vascular anesthesia

External Links

Snippet

The hemostatic management of patients undergoing cardiac surgery is a unique challenge. Since its inception, cardiopulmonary bypass (CPB) has required meticulous attention to maintaining adequate anticoagulation. New anticoagulants and alternative monitoring …
Continue reading at journals.sagepub.com (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material
    • G01N33/49—Blood
    • G01N33/4905—Determining clotting time of blood
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/22—Haematology
    • G01N2800/226—Thrombotic disorders, i.e. thrombo-embolism irrespective of location/organ involved, e.g. renal vein thrombosis, venous thrombosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/22—Haematology
    • G01N2800/222—Platelet disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/22—Haematology
    • G01N2800/224—Haemostasis or coagulation

Similar Documents

Publication Publication Date Title
Shore-Lesserson Evidence based coagulation monitors: heparin monitoring, thromboelastography, and platelet function
Kozek-Langenecker Management of massive operative blood loss
Bolliger et al. Principles and practice of thromboelastography in clinical coagulation management and transfusion practice
Despotis et al. The effect of an intraoperative treatment algorithm on physicians' transfusion practice in cardiac surgery
Rahe-Meyer et al. Thromboelastometry-guided administration of fibrinogen concentrate for the treatment of excessive intraoperative bleeding in thoracoabdominal aortic aneurysm surgery
Reiss Hemostatic defects in massive transfusion: rapid diagnosis and management
Tanaka et al. Perioperative factor concentrate therapy
US7534620B2 (en) Method and device for monitoring platelet function
Tanaka et al. Novel approaches in management of perioperative coagulopathy
US6890299B2 (en) Method and apparatus for monitoring hemostasis in connection with artificial surface devices
Lasne et al. A Study of Platelet Functions with a New Analyzer Using High Shear Stress (PFA100™) in Patients Undergoing Coronary Artery Bypass Graft
Hoenicka et al. Anticoagulation management during multivessel coronary artery bypass grafting: a randomized trial comparing individualized heparin management and conventional hemostasis management
Kanji et al. Optimal tests to minimise bleeding and ischaemic complications in patients on extracorporeal membrane oxygenation
Laine et al. Transfusion threshold of hemoglobin 80 g/L is comparable to 100 g/L in terms of bleeding in cardiac surgery: a prospective randomized study
Machovec et al. Pediatric transfusion algorithms: coming to a cardiac operating room near you
Nilsson et al. Can we rely on the activated clotting time to measure heparin anticoagulation? A clinical evaluation of two ACT monitors
Ganter et al. Monitoring recombinant factor VIIa treatment: efficacy depends on high levels of fibrinogen in a model of severe dilutional coagulopathy
Shore-Lesserson Point-of-care coagulation monitoring for cardiovascular patients: past and present
Narani Thrombelastography in the perioperative period
Mazzeffi et al. The year in coagulation: Selected highlights from 2019
Faraday et al. Utility of whole blood hemostatometry using the Clot Signature Analyzer® for assessment of hemostasis in cardiac surgery
Malhotra Kapoor et al. Evaluation of coagulopathy on veno-arterial ECMO (VA) extracorporeal membrane oxygenation using platelet aggregometry and standard tests: A narrative review
Pluta et al. Assessment of haemostasis and impact of fibrinogen supplementation on clot properties using global haemostasis assays in patients on chronic dialysis
US11169142B2 (en) Viscoelastic analysis in patients with disease associated with cardiovascular system
Hans et al. Impact of 6% hydroxyethyl starch (HES) 130/0.4 on the correlation between standard laboratory tests and thromboelastography (TEG®) after cardiopulmonary bypass